tradingkey.logo
tradingkey.logo
Search

Pacific Biosciences of California Inc

PACB
Add to Watchlist
1.680USD
-0.060-3.45%
Close 07/02, 13:00ETQuotes delayed by 15 min
507.29MMarket Cap
LossP/E TTM

Pacific Biosciences of California Inc

1.680
-0.060-3.45%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

-3.45%

5 Days

+1.82%

1 Month

+3.07%

6 Months

-8.70%

Year to Date

-10.16%

1 Year

+5.00%

Key Figures
1.730Open
1.835High
5.38MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
1.78%Turnover Ratio
1.740Prev. Close
1.670Low
6.26MTurnover
LossP/E Static
94.84P/B
0.00%Div Yield TTM
-15.65%ROA
2.73052wk High
1.01Volume Ratio
-309.85MNet Profit
301.96MShares
-0.4133EPS TTM
2.36Beta
-273.55%ROE
0.96052wk Low
9.48%Amplitude
32.30%Gross Margin
507.29MMarket Cap
1.32Reward/Risk
5.13%Risk Rate

Key Insights

Pacific Biosciences of California Inc's fundamentals are relatively weak, and its growth potential is significant.Its valuation is considered fairly valued, ranking 124 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.46.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Pacific Biosciences of California Inc's Score

Industry at a Glance

Industry Ranking
124 / 204
Overall Ranking
297 / 4565
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Pacific Biosciences of California Inc Highlights

StrengthsRisks
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 160.00M.
Undervalued
The company’s latest PE is -4.07, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 192.85M shares, decreasing 9.18% quarter-over-quarter.
Held by Catherine Wood
Star Investor Catherine Wood holds 37.12M shares of this stock.

Analyst Rating

Based on 8 analysts
Buy
Current Rating
2.458
Target Price
+41.28%
Upside Space

Pacific Biosciences of California Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Pacific Biosciences of California Inc Info

Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
Ticker SymbolPACB
CompanyPacific Biosciences of California Inc
CEOHenry (Christian O)
Websitehttps://www.pacb.com/

FAQs

What is the current price of Pacific Biosciences of California Inc (PACB)?

The current price of Pacific Biosciences of California Inc (PACB) is 1.68.

What is the symbol of Pacific Biosciences of California Inc?

The ticker symbol of Pacific Biosciences of California Inc is PACB.

What is the 52-week high of Pacific Biosciences of California Inc?

The 52-week high of Pacific Biosciences of California Inc is 2.73.

What is the 52-week low of Pacific Biosciences of California Inc?

The 52-week low of Pacific Biosciences of California Inc is 0.96.

What is the market capitalization of Pacific Biosciences of California Inc?

The market capitalization of Pacific Biosciences of California Inc is 507.29M.

Is Pacific Biosciences of California Inc (PACB) currently rated as Buy, Hold, or Sell?

According to analysts, Pacific Biosciences of California Inc (PACB) has an overall rating of Buy, with a price target of 2.46.

What is the Earnings Per Share (EPS TTM) of Pacific Biosciences of California Inc (PACB)?

The Earnings Per Share (EPS TTM) of Pacific Biosciences of California Inc (PACB) is -1.82.